Murugesan Manoharan, M.D., is a surgical Urologic oncologist specializing in the treatment of genitourinary cancers and serves as Chief of Urologic Oncology Surgery at Miami Cancer Institute. He also serves as the Chairman of the Department of Urology at Baptist Health South Florida and a Professor of Urology at Herbert Wertheim College of Medicine, Florida International University. He is a renowned leader in the treatment of Prostate, Kidney, Bladder cancer and other urologic malignancies. Dr. Manoharan is an expert in the field of Minimally invasive surgery including robotic prostatectomy, robotic kidney surgery , Robotic bladder removal and neobladder reconstruction. He specializes in other minimally invasive ablative cancer procedures such as HIFU therapy, Cryotherapy and Nanoknife procedure to treat prostate cancer. He was one of the first urologists in the U.S. to perform robotic bladder removal surgery and reconstruction of neobladder using a pfannensteil incision. Dr. Manoharan’s research interests include stem cell applications, biomarkers, and cancer outcomes.
He has extensive experience training medical students, residents and oncology fellows. He has won many awards for his teaching and clinical excellence as well as his important research work. He serves as an editorial reviewer for several scientific publications. He is also widely published in peer-reviewed medical journals and is an invited speaker at national and international scientific symposiums. He has authored more than 140 scientific articles and 15 text book chapters and has presented papers and posters at over 100 national and international meetings. Dr. Manoharan served as vice chairman and a member of the International Bladder Cancer Guidelines committee, organized by the WHO and Société Internationale d’Urologie.